Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zuhal Umit, Zumrut Sahbudak Bal, Aysin Zeytinoglu, Tansu Gulbahar Aydogan, Ozlem Bag, Gizem Guner Ozenen, Ferda Ozkinay & Zafer Kurugol. (2021) The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka. Human Vaccines & Immunotherapeutics 17:11, pages 4190-4193.
Read now
Read now
Articles from other publishers (5)
Eric M. Vogelsang & Andrea N. Polonijo. (2022) Scarier than the flu shot? : The social determinants of shingles and influenza vaccinations among U.S. older adults. Vaccine 40:47, pages 6747-6755.
Crossref
Crossref
Oluwaseun Sharomi, Ilaria Xausa, Robert Nachbar, Matthew Pillsbury, Ian Matthews, Tanaz Petigara, Elamin Elbasha & Manjiri Pawaskar. (2022) Modeling the Impact of Exogenous Boosting and Universal Varicella Vaccination on the Clinical and Economic Burden of Varicella and Herpes Zoster in a Dynamic Population for England and Wales. Vaccines 10:9, pages 1416.
Crossref
Crossref
Enrique Chacon-Cruz, Estelle Meroc, Sue Ann Costa-Clemens, Ralf Clemens & Thomas Verstraeten. (2021) Economic Evaluation of Universal Varicella Vaccination in Mexico. Pediatric Infectious Disease Journal 41:5, pages 439-444.
Crossref
Crossref
Manjiri Pawaskar, Colleen Burgess, Mathew Pillsbury, Torbjørn Wisløff & Elmira Flem. (2021) Clinical and economic impact of universal varicella vaccination in Norway: A modeling study. PLOS ONE 16:7, pages e0254080.
Crossref
Crossref
Elena Bozzola, Stefano Guolo, Giulia Macchiarulo, Lidia Festa, Giulia Spina, Andrzej Krzysztofiak, Annalisa Grandin, Mauro Bozzola, Massimiliano Raponi & Alberto Villani. (2020) Hospitalization for acute cerebellitis in children affected by varicella: how much does it cost?. Italian Journal of Pediatrics 46:1.
Crossref
Crossref